MedTrace Logo

Differentiated Service Delivery for Antiretroviral Therapy

NCT04383769 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2024-11-25

No results posted yet for this study

Summary

This study is a prospective observational cohort. The target study population is PLHIV who receive ART at hospitals and community-based organizations (CBOs) in Chiang Mai, Ubon Ratchathani, Chonburi, and Songkhla. Participants will receive ART service in the same standard as in the hospital setting. Secondary data will be collected from the medical records already existed in the hospital and CBO systems.

Conditions

  • HIV Infections

Interventions

OTHER

questionnaires survey

data will be collected from the medical records already existed in the hospital and community-based organization (CBO) systems and entered into case report form (CRF). The expected number of participants is 5000. For each participant, the data will be collected prospectively for 24 months and retrospectively up to 5 years from the screening date. This study has no intervention and will not alter ART services whether be standard or DSD-ART at hospitals.

Sponsors & Collaborators

  • Thai Red Cross AIDS Research Centre

    lead OTHER

Principal Investigators

  • Nittaya Phanuphak, MD,Ph.D · Institute of HIV Research and Innovation (IHRI)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-15
Primary Completion
2021-12-15
Completion
2023-12-15

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04383769 on ClinicalTrials.gov